CLEVELAND, May 28, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced it was among an elite group Northeast Ohio companies to be recognized at The 2013 Leading EDGE Awards on May 23 at Lorain County Community College in Elyria, Ohio.
"We are honored to be recognized as a company that creates value for its community for the fourth year in a row," stated Laurence P. Birch, DATATRAK's Chairman of the Board and CEO. "We appreciate that the Leading EDGE organization values our leadership position in the cloud-based eClinical solutions market and the resulting growth of the DATATRAK ONE™ unified software suite as it safely accelerates drug development from Concept to Cure®."
Join DATATRAK Thought Leaders:
Tweet: DATATRAK Recognized with Leading EDGE Award http://bit.ly/114GK2v
EDGE drives growth for companies by bringing together their leadership teams to share best practices and inspire each other to pursue the biggest opportunities. EDGE is a 501(c)(3) non-profit, and is the only Northeast Ohio economic development group that is focused on helping mid-sized companies strengthen their leadership teams in order to take their companies to the next level. For more information, visit http://www.edgef.org.
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on May 15 announcing its results for the first quarter of 2013. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.